183 related articles for article (PubMed ID: 18205839)
1. Strategies to optimize the use of targeted agents for tumor therapy.
Becker JC; Ugurel S; Schrama D
J Dtsch Dermatol Ges; 2008 Apr; 6(4):281-5. PubMed ID: 18205839
[TBL] [Abstract][Full Text] [Related]
2. Strategies for optimizing combinations of molecularly targeted anticancer agents.
Dancey JE; Chen HX
Nat Rev Drug Discov; 2006 Aug; 5(8):649-59. PubMed ID: 16883303
[TBL] [Abstract][Full Text] [Related]
3. Nanoscale delivery systems for multiple drug combinations in cancer.
Cao Y; Wang B; Lou D; Wang Y; Hao S; Zhang L
Future Oncol; 2011 Nov; 7(11):1347-57. PubMed ID: 22044207
[TBL] [Abstract][Full Text] [Related]
4. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
Shapira A; Livney YD; Broxterman HJ; Assaraf YG
Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of metastatic disease: implications for current therapy and for the development of new therapeutic strategies.
Poste G
Cancer Treat Rep; 1986 Jan; 70(1):183-99. PubMed ID: 3510734
[TBL] [Abstract][Full Text] [Related]
6. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.
Sabbah M; Emami S; Redeuilh G; Julien S; Prévost G; Zimber A; Ouelaa R; Bracke M; De Wever O; Gespach C
Drug Resist Updat; 2008; 11(4-5):123-51. PubMed ID: 18718806
[TBL] [Abstract][Full Text] [Related]
7. Slaying RAS with a synthetic lethal weapon.
Bommi-Reddy A; Kaelin WG
Cell Res; 2010 Feb; 20(2):119-21. PubMed ID: 20118966
[No Abstract] [Full Text] [Related]
8. Multitargeted therapy: can promiscuity be praised in an era of political correctness?
Jimeno A; Hidalgo M
Crit Rev Oncol Hematol; 2006 Aug; 59(2):150-8. PubMed ID: 16843676
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic alterations and cancer: new targets for therapy.
Allen A
IDrugs; 2007 Oct; 10(10):709-12. PubMed ID: 17899489
[TBL] [Abstract][Full Text] [Related]
10. Drug development for cancer chemoprevention: focus on molecular targets.
Johnson KA; Brown PH
Semin Oncol; 2010 Aug; 37(4):345-58. PubMed ID: 20816505
[TBL] [Abstract][Full Text] [Related]
11. Combining targeted therapies and drugs with multiple targets in the treatment of NSCLC.
Maione P; Gridelli C; Troiani T; Ciardiello F
Oncologist; 2006 Mar; 11(3):274-84. PubMed ID: 16549812
[TBL] [Abstract][Full Text] [Related]
12. Tailoring Ras-pathway--inhibitor combinations for cancer therapy.
Blum R; Kloog Y
Drug Resist Updat; 2005 Dec; 8(6):369-80. PubMed ID: 16356760
[TBL] [Abstract][Full Text] [Related]
13. Targeted therapy of hepatocellular cancer.
Wysocki PJ
Expert Opin Investig Drugs; 2010 Feb; 19(2):265-74. PubMed ID: 20074016
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy of bortezomib with novel targeted agents: an emerging treatment strategy.
Wright JJ
Clin Cancer Res; 2010 Aug; 16(16):4094-104. PubMed ID: 20682705
[TBL] [Abstract][Full Text] [Related]
15. New targets for non-small-cell lung cancer therapy.
Alvarez M; Roman E; Santos ES; Raez LE
Expert Rev Anticancer Ther; 2007 Oct; 7(10):1423-37. PubMed ID: 17944567
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic targets in hematological malignancies: combination therapies with HDACis and demethylating agents.
Bishton M; Kenealy M; Johnstone R; Rasheed W; Prince HM
Expert Rev Anticancer Ther; 2007 Oct; 7(10):1439-49. PubMed ID: 17944568
[TBL] [Abstract][Full Text] [Related]
17. Cancer trial assesses clinical benefit of gene-targeted treatment.
Katsnelson A
Nat Biotechnol; 2014 Apr; 32(4):306. PubMed ID: 24714466
[No Abstract] [Full Text] [Related]
18. Overcoming apoptosis deficiency of melanoma-hope for new therapeutic approaches.
Eberle J; Kurbanov BM; Hossini AM; Trefzer U; Fecker LF
Drug Resist Updat; 2007 Dec; 10(6):218-34. PubMed ID: 18054518
[TBL] [Abstract][Full Text] [Related]
19. Reanalysis of cancer drugs: old drugs, new tricks.
Vande Woude GF; Kelloff GJ; Ruddon RW; Koo HM; Sigman CC; Barrett JC; Day RW; Dicker AP; Kerbel RS; Parkinson DR; Slichenmyer WJ
Clin Cancer Res; 2004 Jun; 10(11):3897-907. PubMed ID: 15173099
[No Abstract] [Full Text] [Related]
20. Polymeric micelles drug delivery system in oncology.
Gong J; Chen M; Zheng Y; Wang S; Wang Y
J Control Release; 2012 May; 159(3):312-23. PubMed ID: 22285551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
